SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI
CCSI 22.47+3.5%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: CatLady who wrote (3417)6/23/1998 9:29:00 PM
From: JanyBlueEyes   of 5736
 
<<It claims that a majority of its revenues will come from sales of a disposable calibration and contamination guard that will be required for each test performed using its instrument. This means that the Chromatics device needs to be recalibrated, or at least verified, after each use and that it requires contact with the patient's skin.>>

From Message 4821987 :

Similarly, Asensio further neglected to mention that CCSI's Colormate(TM) TLc-BiliTest(TM) requires a proprietary disposable calibration standard which is used for each test performed to prevent cross contamination between patients and ensure the accuracy of each reading.

There will be a charge for each test performed by the Colormate(TM) TLc-BiliTest(TM) device, in addition to the instrument cost. Without this charge per test, CCSI would only be selling instruments which CCSI has never considered to be the major income potential for this market, nor even included in the existing market estimates stated by CCSI.

Mr. Asensio's statement that the potential market for all bilirubinometers is extremely limited is misleading as he is referring here to the laboratory invasive blood serum test instrument market study for the instrument alone without the charge for each test again.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext